Medical Program

EU Providing Medication

Providing Medication for Chronic diseases for Syrian Refugees

and their Lebanese Hosting Communities

 

The EU funded the YMCA medical program to avoid shortages in the medical stock, ensuring that patients with chronic illness from the Syrian refugees and from the vulnerable Lebanese hosting communities, will continuously receive their chronic medication. The support of EU is life-saving and crucial in helping the medical program catering to the exponential need of chronic medication due to the Syrian refugee's crisis, and the increased reliance of Lebanese vulnerable clusters on subsidized medical support.

 

Supported patients through the EU project:

Patients by Illness:

Illness  Percentage of Incidence
ANTIDEPRESSANT 0.29%
ASTHMATICS 1.40%
CARDIOVASCULAR 23.34%
COAGULATION PROBLEMS 1.17%
DIABETICS 12.53%
EPILEPSY 2.31%
GOUT 2.04%
HYPERLIPIDEMIA 7.93%
HYPERTENSION 14.90%
NEUROLEPTIC 1.61%
OCULAR HYPERTENSION 0.13%
OSTEOPOROSIS 3.94%
OTHERS 17.25%
RUMATHISME 0.30%
THYROID-PROBLEMS 1.58%
TRANQUILIZER 0.69%
ULCER 8.59%